Name: Metabolic Disorders Therapeutics Market Size, Competitive Landscape and Market Forecast - 2029
Brand: DataM Intelligence
SKU: DMPH1331
Price: 4350 USD
Availability: InStock

Metabolic Disorders Therapeutics Market Size Share Growth Opportunities and Forecast 2022

Metabolic Disorders Therapeutics Market Size, Competitive Landscape and Market Forecast - 2029

<h2>Global Metabolic Disorders Therapeutics Market is segmented&nbsp;By Type (Enzyme Replacement Therapy, Cellular Transplantation, Small Molecule Based Therapy, Substrate Reduction Therapy, Gene Therapy, Drug Therapy),&nbsp;By Route of Administration (Oral, Parenteral, Others),&nbsp;By Application (Lysosomal Storage diseases, Hypercholesterolemia, Obesity, Diabetes, Others),&nbsp;and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2022-2029</h2>

&nbsp;

<h2>Market Overview</h2>

<blockquote>
The Global &quot;Metabolic Disorders Therapeutics Market&quot;&nbsp;is expected to grow at a high&nbsp;<a href="https://www.datamintelligence.com/download-sample/metabolic-disorders-therapeutics-market">CAGR</a>&nbsp;during the forecasting period (2022-2029).
</blockquote>

<h3 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Trending Topics</h3>

<a href="https://www.datamintelligence.com/research-report/neurometabolic-disorders-market">Neurometabolic Disorders Market</a>

<a href="https://www.datamintelligence.com/research-report/cardiometabolic-monitoring-products-market">Cardiometabolic Monitoring Products Market</a>

<a href="https://www.datamintelligence.com/research-report/acute-intermittent-porphyria-market">Acute Intermittent Porphyria Market</a>

<h3>&nbsp;</h3>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Table of Contents</h2>

1. Methodology and Scope

1.1. Research Methodology

1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

3.1. Market Snippet by Type

3.2. Market Snippet by Route of Administration

3.3. Market Snippet by Application

3.4. Market Snippet by Region

4. Market Dynamics

4.1. Market Impacting Factors

4.1.1. Drivers

4.1.1.1. Growing incidences of obesity, diabetes

4.1.2. Restraints

4.1.2.1. High cost of treatment for metabolic disorder

4.1.3. Opportunity

4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter&amp;#39;s Five Forces Analysis

5.2. Regulatory Analysis

5.3. Patent Analysis

6. Epidemiology Analysis

7. Pipeline Analysis

8. By Type

8.1.1. Introduction

8.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type

8.1.3. Market Attractiveness Index, By Type

8.2. Enzyme Replacement Therapy

8.2.1. Introduction

8.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026

8.3. Cellular Transplantation

8.4. Small Molecule Based Therapy

8.5. Substrate Reduction Therapy

8.6. Gene Therapy

8.7. Drug Therapy

9. By Route of Administration

9.1.1. Introduction

9.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration

9.1.3. Market Attractiveness Index, By Route of Administration

9.2. Oral

9.2.1. Introduction

9.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026

9.3. Parenteral

9.4. Others

10. By Application

10.1.1. Introduction

10.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

10.1.3. Market Attractiveness Index, By Application

10.2. Lysosomal Storage diseases

10.2.1. Introduction

10.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026

10.2.2.1. Gaucher&rsquo;s Disease

10.2.2.2. Metachromatic Leukodystrophy

10.2.2.3. Hurler-Scheie

10.2.2.4. Sanfilipo A

10.2.2.5. Others

10.3. Hypercholesterolemia

10.4. Obesity

10.5. Diabetes

10.6. Others

11. By Region

11.1. Introduction

11.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region

11.1.2. Market Attractiveness Index, By Region

11.2. North America

11.2.1. Introduction

11.2.2. Key Region-Specific Dynamics

11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type

11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration

11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

11.2.6.1. The U.S.

11.2.6.2. Canada

11.2.6.3. Mexico

11.3. Europe

11.3.1. Introduction

11.3.2. Key Region-Specific Dynamics

11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type

11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration

11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

11.3.6.1. Germany

11.3.6.2. The U.K.

11.3.6.3. France

11.3.6.4. Italy

11.3.6.5. Spain

11.3.6.6. Rest of Europe

11.4. South America

11.4.1. Introduction

11.4.2. Key Region-Specific Dynamics

11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type

11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration

11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

11.4.6.1. Brazil

11.4.6.2. Argentina

11.4.6.3. Rest of South America

11.5. Asia Pacific

11.5.1. Introduction

11.5.2. Key Region-Specific Dynamics

11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type

11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration

11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

11.5.6.1. China

11.5.6.2. India

11.5.6.3. Japan

11.5.6.4. Australia

11.5.6.5. Rest of Asia Pacific

11.6. Middle East &amp;amp; Africa

11.6.1. Introduction

11.6.2. Key Region-Specific Dynamics

11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), ByType

11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration

12. Competitive Landscape

12.1. Competitive Scenario

12.2. Competitor Metabolic Disorders Therapeutics Strategy Analysis

12.3. Comparative Product Portfolio Analysis

12.4. Market Positioning/Share Analysis

12.5. Mergers and Acquisitions Analysis

13. - Company Profiles

13.1. Sanofi S.A

13.1.1. Company Overview

13.1.2. Product Portfolio and Description

13.1.3. Key Highlights

13.1.4. Financial Overview

13.2. Merck KgaA

13.3. Amgen, Inc

13.4. AstraZeneca PLC

13.5. Actelion Pharmaceuticals Ltd

13.6. AbbVie, Inc.

13.7. Bristol-Myers Squibb Company

13.8. Cipla, Inc, Inc.

13.9. CymaBay Therapeutics, Inc

13.10. Boehringer Ingelheim GmbH

14. DataM Intelligence

14.1. Appendix

14.2. About Us and Services

14.3. Contact Us